Article
Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes
Registro en:
ESPÍNDOLA, Otávio M. et al. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes. International Journal of Infectious Diseases, v.57, p.116–122, 2017.
1201-9712
10.1016/j.ijid.2017.01.037
1878-3511
Autor
Espíndola, Otávio M.
Vizzoni, Alexandre G.
Lampe, Elisabeth
Serpa, Maria José Andrada
Araújo, Abelardo Q. C.
Leite, Ana Claudia C.
Resumen
Human T-cell lymphotropic virus type 1 (HTLV-1) infection is associated with neurological abnormalities, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and peripheral neuropathy (PN). Hepatitis C virus (HCV) infection is the leading cause of chronic liver disease worldwide, and causes PN in approximately 9% of patients. Because the interplay between these potentially neuropathogenic viruses in the same individual is still poorly understood, the clinical and laboratory outcomes of co-infected patients were evaluated and compared with those of controls. 2030-01-01